Our pipeline is comprised of innovative therapeutic products that have the potential for optimized value creation using our partnership-enabled business model.
Our flagship product candidates, Virtue SAB and BackBeat CNT, exemplify key criteria that characterize innovations optimized for strategic partnerships:
*Minimally Invasive Surgical (MIS) solutions
Virtue® SAB is not approved for commercial use in the US
BackBeat CNT™ is not approved for commercial use in the US
© 2022 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01